DANIEL LORRAIN plan to sell securities of Contineum Therapeutics, Inc. under Form 144

DANIEL LORRAIN filed Form 144 to notify SEC of plan to sell 4170 units of Contineum Therapeutics, Inc. securities around 2026-05-01, with aggregate market value of $53,459.40. The total outstanding units is 32673536.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months include: On 04/06/2026, sold 4170 units for $56013.94; On 03/02/2026, sold 4170 units for $62585.03; On 02/25/2026, sold 3824 units for $61227.91; On 02/24/2026, sold 4300 units for $68936.04; On 02/19/2026, sold 100 units for $1600.00; On 02/11/2026, sold 400 units for $6400.00; On 02/03/2026, sold 4170 units for $62305.22;